Evidence map›Paper›PMID 38510473›Full record

ArticleGenes & diseases2024

Comprehensive genomic analysis of early and late-onset hepatocellular carcinoma.

Jialin Yang, Chao Chen, Song Wang, Yaru Zhang, Jiaohui Pang, Yajun Wang, Qiuxiang Ou, Hao Jiang, Juying Liu

Abstract read
In one paragraph

Article in Genes & diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jialin YangDepartment of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan 610041, China.
Chao ChenJinling Hospital, Department of Oncology, Nanjing Medical University, Nanjing, Jiangsu 210002, China.
Song WangGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu 210000, China.
Yaru ZhangGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu 210000, China.
Jiaohui PangGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu 210000, China.
Yajun WangDepartment of Oncology, Haian Hospital of Traditional Chinese Medicine, Haian, Jiangsu 226600, China.
Qiuxiang OuGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu 210000, China.
Hao JiangInterventional Therapy Department, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, China.
Juying LiuInterventional Therapy Department, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38510473
PMCPMC10950800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.